Actifit may improve meniscus preservation in patients with post meniscectomy syndrome.

Actifit may improve meniscus preservation in patients with post meniscectomy syndrome

Actifit is a solution for patients that suffer from sustained symptoms after partial meniscectomy and meniscus repair. This is also called post meniscectomy syndrome. There are several treatment options to prevent progression and minimize symptoms including non-surgical and surgical options.

One of the surgical options is meniscal reconstruction with Actifit. This significantly improves pain, quality of life (QoL) and function in daily living (ADL) & sport and recreation up to 10 years after implantation. Many patients have an improved quality of life thanks to Actifit. When is Actifit a suitable surgical option for your patient? Find out by downloading our treatment algorithm.

Actifit may improve meniscus preservation in patients with post meniscectomy syndrome.

Actifit is a one-of-a-kind biodegradable, synthetic meniscus scaffold that facilitates the body’s own natural healing processes.

Actifit may improve meniscus preservation in patients with post meniscectomy syndrome.

Actifit: A scaffold with a 10-year survival rate of 80%

Meniscal reconstruction with Actifit may lower the risk of osteoarthritis and may delay or prevent the need for joint replacement.. The 10-year survival rate of Actifit is around 80%. The scaffold can be tailored to the meniscal defect of the patient and is validated in over 30 peer-reviewed clinical publications.